Today: 21 May 2026
Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

New York, Jan 20, 2026, 18:51 EST — After-hours

  • Lam Research closed the regular session down 0.25%, with little movement in after-hours trading
  • Tech shares dipped after renewed tariff warnings rattled the market, stirring volatility among chipmakers
  • UBS lifted its price target for Lam, as investors look ahead to the Jan. 28 earnings report for guidance

Lam Research Corp shares slipped roughly 0.2% in after-hours trading Tuesday, holding close to $222 following a choppy session that ended with little change.

The chip-equipment maker faces a crucial week, with political tensions shaping risk appetite and its earnings report due in eight days. Lam has announced its quarterly financial conference call will take place on Jan. 28.

The date is crucial since Lam provides wafer fabrication equipment—key tools for chip production—and investors often interpret its outlook as a gauge of chipmakers’ appetite for new plants and upgrades.

Wall Street stumbled Tuesday, hit by concerns over U.S. President Donald Trump’s tariff threats targeting Europe. The news spooked investors, driving them away from riskier assets and dragging down tech-focused indexes.

Trump announced that an extra 10% tariff will kick in on Feb. 1 for products from eight European nations, linking the measure to his bid for U.S. control over Greenland.

Lam’s decline was relatively mild compared to others in the sector. Applied Materials slid 2.7%, while inspection-tool specialist KLA tumbled 5.2% during the regular session, MarketWatch data shows.

UBS gave bulls a boost, lifting its price target on Lam to $255 from $200 while maintaining a “Buy” rating. The firm cited ongoing checks that suggest a solid Q2 performance and an optimistic guidance outlook. TipRanks

Shares swung between roughly $217.61 and $226.15 on Tuesday, finally closing close to $222.

A lot can go sideways. A prolonged trade dispute might freeze budgets and throw supply chains into chaos, while even a robust chip cycle can stumble if customers delay their orders. “Geopolitical tensions have dented sentiment and cooled early-year exuberance,” said Nuveen strategist Laura Cooper. Reuters

Investors are keeping an eye on whether the tariff dispute will escalate into wider policy battles, as markets monitor the legal and political fallout from Trump’s trade moves.

Lam’s earnings report and conference call on Jan. 28 will be key. Investors will be listening closely for any shifts in management’s outlook on demand, delivery schedules, and customer spending. This could reshape forecasts for the stock.

Stock Market Today

  • EnerSys Q1 CY2026 Sales Beat Estimates with Optimistic Guidance
    May 20, 2026, 6:18 PM EDT. Battery maker EnerSys (NYSE:ENS) reported Q1 CY2026 sales of $988 million, up 1.4% year on year, beating analyst estimates by 1.5%. Adjusted earnings per share (EPS) stood at $3.19, a 6.6% beat over consensus. Guidance for Q2 revenue is $935 million, 2.2% above estimates, with adjusted EPS guidance also exceeding forecasts. Despite a 6% decline in sales volumes, revenue growth was supported by price increases. Free cash flow turned negative at -$12.66 million, down from $105 million last year. EnerSys continues to push its lithium data center and battery energy storage system solutions, signaling long-term innovation. The company's subdued 4.7% annualized revenue growth over five years contrasts with sector expectations, raising caution among investors.

Latest articles

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

21 May 2026
AEVEX Corp. shares surged over 10% after hours Wednesday following a first-quarter profit of $21 million and new U.S. Air Force contracts worth $15.6 million. Revenue jumped to $216.7 million, beating estimates. The company, which went public in April, raised its full-year revenue outlook to $600–$620 million. The stock had closed regular trading at $26.27, down 0.23%.
Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

21 May 2026
Jupiter Neurosciences shares fell 37% to $0.205 Wednesday after announcing a proposed U.S. licensing deal for PharmAla Biotech’s MDMA-based ALA-002 and a $2 million stock offering. Trading volume topped 230 million shares. The licensing agreement is non-binding, with a potential value over $100 million, and gives Jupiter 90 days to finalize terms. Jupiter reported a $2.06 million Q1 net loss and $2.36 million in cash.
Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

21 May 2026
Urban Outfitters posted record first-quarter net income of $115.7 million and sales of $1.48 billion, beating analyst estimates. Shares closed up 4.05% at $71.67 before slipping to $70.55 in after-hours trading. Comparable retail sales rose 5.6%, with strong gains at FP Group, Urban Outfitters, and Nuuly. Gross profit rate edged down to 36.6% as tariffs pressured costs.
Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps
Previous Story

Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps

Chevron stock price slips as Tengiz shutdown headlines hit CVX; Turkey talks add fresh focus
Next Story

Chevron stock price slips as Tengiz shutdown headlines hit CVX; Turkey talks add fresh focus

Go toTop